These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 208764)

  • 21. N-Hydroxylation of arylamides by the rat and guinea pig. Evidence for substrate specificity and participation of cytochrome P1-450.
    Gutmann HR; Bell P
    Biochim Biophys Acta; 1977 Jun; 498(1):229-43. PubMed ID: 884151
    [No Abstract]   [Full Text] [Related]  

  • 22. Localization of alpha-fetoprotein by immunofluorescence in hyperplastic nodules during hepatocarcinogenesis induced by 2-acetylaminofluorene.
    Okita K; Gruenstein M; Klaiber M; Farber E
    Cancer Res; 1974 Oct; 34(10):2758-63. PubMed ID: 4370173
    [No Abstract]   [Full Text] [Related]  

  • 23. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE; Gutmann HR
    Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene.
    Rudo K; Meyers WC; Dauterman W; Langenbach R
    Cancer Res; 1987 Nov; 47(22):5861-7. PubMed ID: 2822235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of hepatocytes by subcarcinogenic exposure to n-2-fluorenylacetamide.
    Becker FF
    Cancer Res; 1975 Jul; 35(7):1734-6. PubMed ID: 165882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
    Weeks CE; Allaben WT; Louie SC; Lazear EJ; King CM
    Cancer Res; 1978 Mar; 38(3):613-8. PubMed ID: 203386
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice.
    Reddy TV; Weisburger EK; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subnanogram estimation of the proximate carcinogen N-hydryxy-2-fluorenylacetamide by gas-liquid chromatography.
    Razzouk C; Lhoest G; Roberfroid M; Mercier M
    Anal Biochem; 1977 Nov; 83(1):194-203. PubMed ID: 920936
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic controls in precancerous liver: defective control of cholesterol synthesis in rats fed N-2-fluorenylacetamide.
    Horton BJ; Sabine JR
    Eur J Cancer (1965); 1971 Oct; 7(5):459-65. PubMed ID: 4334170
    [No Abstract]   [Full Text] [Related]  

  • 30. Early events during liver carcinogenesis involving two carcinogen:protein complexes.
    Blackburn GR; Andrews JP; Custer RP; Sorof S
    Cancer Res; 1981 Oct; 41(10):4039-49. PubMed ID: 6269733
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
    Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
    Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental pattern of 3-methylcholanthrene-inducible mutagenic activation of N-2-fluorenylacetamide, 2-fluorenamine, and 2,4-diaminoanisole in the rabbit.
    Aune T; Dybing E; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Apr; 64(4):765-9. PubMed ID: 6928989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells.
    Glatt H; Oesch F
    Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF; Fox RA; Klein KM; Wolman SR
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract]   [Full Text] [Related]  

  • 35. Activation of 2-acetylaminofluorene in the nuclei of rat liver.
    Kawajiri K; Yonekawa H; Hara E; Tagashira Y
    Cancer Res; 1979 Mar; 39(3):1089-93. PubMed ID: 427750
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfation of N-hydroxy-2-acetylaminofluorene in normal and nodular liver from male Wistar rats.
    Blanck A; Wicksell L; Eriksson LC
    Toxicol Pathol; 1987; 15(1):103-5. PubMed ID: 3576071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deacetylation to 2-aminofluorene as a major initial reaction in the microsomal metabolism of 2-acetylaminofluorene to mutagenic products in preparations from rabbit lung and liver.
    Aune T; Vanderslice RR; Croft JE; Dybing E; Bend JR; Philpot RM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5859-66. PubMed ID: 4053056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing effect of chemicals on production of hyperplastic liver nodules induced by n-2-fluorenylacetamide in hepatectomized rats.
    Ito N; Tatematsu M; Hirose M; Nakanishi K; Murasaki G
    Gan; 1978 Feb; 69(1):143-4. PubMed ID: 416986
    [No Abstract]   [Full Text] [Related]  

  • 39. [Early histochemical markers of hepatocarcinogenesis].
    Vinarchuk MP; Bykorez AI
    Eksp Onkol; 1984; 6(1):11-6. PubMed ID: 6209085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro metabolism and activation of carcinogenic aromatic amines by subcellular fractions of human liver.
    Dybing E; von Bahr C; Aune T; Glaumann H; Levitt DS; Thorgeirsson SS
    Cancer Res; 1979 Oct; 39(10):4206-11. PubMed ID: 476655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.